These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29377992)

  • 1. Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells.
    Keller A; Dziedzicka D; Zambelli F; Markouli C; Sermon K; Spits C; Geens M
    Hum Reprod Update; 2018 Mar; 24(2):162-175. PubMed ID: 29377992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X chromosome inactivation in human pluripotent stem cells as a model for human development: back to the drawing board?
    Geens M; Chuva De Sousa Lopes SM
    Hum Reprod Update; 2017 Sep; 23(5):520-532. PubMed ID: 28582519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
    Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
    Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic instability in human pluripotent stem cells.
    Nguyen HT; Geens M; Spits C
    Hum Reprod Update; 2013; 19(2):187-205. PubMed ID: 23223511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
    Keller A; Spits C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
    Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
    Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell heterogeneity in human pluripotent stem cells.
    Yang S; Cho Y; Jang J
    BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications in the embryonic and induced pluripotent stem cells.
    Godini R; Lafta HY; Fallahi H
    Gene Expr Patterns; 2018 Sep; 29():1-9. PubMed ID: 29625185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic aberrations in human pluripotent stem cells.
    Bar S; Benvenisty N
    EMBO J; 2019 Jun; 38(12):. PubMed ID: 31088843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of DNA methylation on the
    Sekiya A; Takasawa K; Arai Y; Horike SI; Akutsu H; Umezawa A; Nishino K
    Regen Ther; 2022 Dec; 21():620-630. PubMed ID: 36514370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.
    Ramos-Mejia V; Melen GJ; Sanchez L; Gutierrez-Aranda I; Ligero G; Cortes JL; Real PJ; Bueno C; Menendez P
    Mol Ther; 2010 Dec; 18(12):2173-81. PubMed ID: 20736931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types.
    Pal R; Totey S; Mamidi MK; Bhat VS; Totey S
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1230-43. PubMed ID: 19546356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Early Germ-Layer Specification Bias in Human Pluripotent Stem Cells.
    Keller A; Krivec N; Markouli C; Spits C
    Methods Mol Biol; 2022; 2429():57-72. PubMed ID: 35507155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine.
    Walia B; Satija N; Tripathi RP; Gangenahalli GU
    Stem Cell Rev Rep; 2012 Mar; 8(1):100-15. PubMed ID: 21671061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue of Origin, but Not XCI State, Influences Germ Cell Differentiation from Human Pluripotent Stem Cells.
    Chang YW; Overeem AW; Roelse CM; Fan X; Freund C; Chuva de Sousa Lopes SM
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.